Chapter 8 – Laboratory Detection of Human Retroviral Infection

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  2004-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-012764051-8/50010-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pneumocystis pneumonia--Los Angeles.

  2006cited by this paper
• What's new in the updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis?

  2006cited by this paper
• Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III)

  2004cited by this paper
• Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors

  2002cited by this paper
• Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA

  2002cited by this paper
• Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infection.

  2002cited by this paper
• Use of laboratory tests and clinical symptoms for identification of primary HIV infection

  2002cited by this paper
• HIV transmissions from a window-period platelet donation.

  2001cited by this paper
• Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA

  2001cited by this paper
• Absence of evidence of infection with divergent primate T‐lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results

  2000cited by this paper
• Performance Characteristics of the QUANTIPLEX HIV-1 RNA 3.0 Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

  2000cited by this paper
• Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases

  2000cited by this paper
• Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors.

  2000cited by this paper
• Comparative evaluation of 14 immunoassays for detection of antibodies to the human T‐lymphotropic virus types I and II using panels of sera from Sweden and West Africa

  1999cited by this paper
• Sensitivity and specificity of human T‐lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV‐II

  1999cited by this paper
• Redefining the HIV‐infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood‐borne transmission

  1999cited by this paper
• Detection of Antibodies to Human Immunodeficiency Virus Type 1 in Oral Fluids: A Large-Scale Evaluation of Immunoassay Performance

  1998cited by this paper
• New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

  1998cited by this paper
• High Throughput Assay for the Simultaneous or Separate Detection of Human Immunodeficiency Virus (HIV) and Hepatitis Type C Virus (HCV)

  1998cited by this paper
• Are HTLV-II-seropositive injection drug users at increased risk of bacterial pneumonia, abscess, and lymphadenopathy?

  1997cited by this paper
• Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.

  1997cited by this paper
• Evaluation of a System Using Oral Mucosal Transudate for HIV-1 Antibody Screening and Confirmatory Testing

  1997cited by this paper
• Quantification of HIV-1 using multiple competitors in a single-tube assay.

  1996cited by this paper
• Plasma HIV viremia and viral load in lymph nodes

  1996cited by this paper
• Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II.

  1996cited by this paper
• The risk of HIV transmission by screened blood.

  1996cited by this paper
• Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

  1996cited by this paper
• Quantitative multiple competitive PCR of HIV-1 DNA in a single reaction tube.

  1996cited by this paper
• Comparison of four enzyme immunoassays for detection of human T-cell lymphotropic virus type 2 antibodies

  1996cited by this paper
• HIV viral load markers in clinical practice

  1996cited by this paper
• Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

  1996cited by this paper
• Risques résiduels de transmission virale par transfusion et estimation de l'impact de tests supplémentaires de dépistage

  1996cited by this paper
• Viral load and response to treatment of HIV.

  1996cited by this paper
• No-needle HIV test approved by FDA.

  1996cited by this paper
• V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.

  1996cited by this paper
• The Risk of Transfusion-Transmitted Viral Infections

  1996cited by this paper
• Paediatric HIV infection.

  1996cited by this paper
• Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor

  1995cited by this paper
• Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO‐) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV‐I versus HTLV‐II

  1995cited by this paper
• HIV-1 group O sensitivity to antiretroviral drugs.

  1995cited by this paper
• Time to HIV seroconversion after needlestick injury.

  1995cited by this paper
• Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion

  1995cited by this paper
• Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group

  1995cited by this paper
• The evolving molecular epidemiology of HIV‐1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials

  1995cited by this paper
• Nucleotide Sequence and Restriction Fragment Length Polymorphism Analysis of the Long Terminal Repeat of Human T Cell Leukemia Virus Type II

  1995cited by this paper
• Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.

  1995cited by this paper
• Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

  1995cited by this paper
• HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients

  1994cited by this paper
• Detection of antibody IgG to HIV‐1 in urine by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens for diagnosis of HIV‐1 infection

  1994cited by this paper
• Rapid Genetic Characterization of HIV Type 1 Strains from Four World Health Organization-Sponsored Vaccine Evaluation Sites Using a Heteroduplex Mobility Assay

  1994cited by this paper
• Viral Variability and Serum Antibody Response in a Laboratory Worker Infected with HIV Type 1 (HTLV Type IIIB)

  1994cited by this paper
• Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody

  1994cited by this paper
• HIV AND BLOOD TRANSFUSIONS: FOCUS ON SEROCONVERSION

  1994cited by this paper
• Human T cell lymphotropic virus: necessity for and feasibility of a vaccine.

  1994cited by this paper
• The evolving epidemiology of human T lymphotropic virus type II.

  1994cited by this paper
• T‐cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques

  1994cited by this paper
• Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences.

  1994cited by this paper
• Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.

  1994cited by this paper
• HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.

  1994cited by this paper
• HIV: Between Past and Future

  1994cited by this paper
• HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains

  1994cited by this paper
• Blood Donations Indeterminate in HIV‐1 Western Blot Analysed by IgM Immunoblot and Polymerase Chain Reaction

  1993cited by this paper
• Cellular immune factors associated with mother‐to-infant transmission of HIV

  1993cited by this paper
• The fastest genome evolution ever described: HIV variation in situ.

  1993cited by this paper
• A strategy for prophylactic vaccination against HIV.

  1993cited by this paper
• Misdiagnosis of HTLV‐II infection using HTLV‐I screening assays

  1993cited by this paper
• Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection

  1993cited by this paper
• Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

  1993cited by this paper
• HIV Antibody EIA and Western Blot Assay Results on Paired Serum and Saliva Specimens

  1993cited by this paper
• HIV-1 antibody serum negativity with urine positivity.

  1993cited by this paper
• Evaluation of the automated VIDAS system for the detection of anti-HIV-1 and anti-HIV-2 antibodies.

  1993cited by this paper
• Dental HIV transmission?

  1993cited by this paper
• HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate.

  1993cited by this paper
• Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus.

  1993cited by this paper
• Automated closed-vessel system for in vitro diagnostics based on polymerase chain reaction.

  1993cited by this paper
• Identification of Human T Cell Leukemia Virus Type IIb Infection in the Wayu, an Aboriginal Population of Colombia

  1993cited by this paper
• Nucleotide Sequence Analysis of Human T Cell Leukemia Virus, Type II (HTLV-II) Isolates

  1993cited by this paper
• A Comparative Study of Saliva and OraSure® Oral Fluid

  1993cited by this paper
• A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

  1993cited by this paper
• Transmission of HIV infection by seronegative blood in Thailand.

  1993cited by this paper
• Qualitative and quantitative detection of HIV‐1 RNA by nucleic acid sequence‐based amplification

  1993cited by this paper
• Phylogenetic analysis of gag genes from 70 international HIV‐1 isolates provides evidence for multiple genotypes

  1993cited by this paper
• Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.

  1993cited by this paper
• Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.

  1993cited by this paper
• Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.

  1993cited by this paper
• Antigenic variation of the dominant gp41 epitope in Africa.

  1993cited by this paper
• HIV infection and the healthcare worker.

  1992cited by this paper
• Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

  1992cited by this paper
• Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

  1992cited by this paper
• Multiple isolates and characteristics of human T-cell leukemia virus type II

  1992cited by this paper
• Antibody-capture particle-adherence test for antibody to HIV-1 in urine.

  1992cited by this paper
• Missed Human Immunodeficiency Virus Seroconversion

  1992cited by this paper
• Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users.

  1992cited by this paper
• A Sensitive Viral Capture Assay for Detection of Plasma Viremia in HIV-Infected Individuals

  1992cited by this paper
• Detection of human immunodeficiency virus type 1 (HIV-1) in urine cell pellets from HIV-1-seropositive individuals

  1992cited by this paper
• Improved Detection of HIV‐2 DNA in Clinical Samples Using a Nested Primer‐Based Polymerase Chain Reaction

  1992cited by this paper
• Antibodies to HIV-1 in urine of children of HIV-1-infected women.

  1992cited by this paper
• False‐positive HIV antigens related to emergence of a 25–30 kD protein detected in organ recipients

  1992cited by this paper
• Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991.

  1992cited by this paper
• Chronic neurodegenerative disease associated with HTLV-II infection.

  1992cited by this paper

• Counterproductive contributions to African epidemiology

  2017cites this paper
• Diagnóstico rápido de la infección por VIH/sida

  2014cites this paper
• HIV Tests Are Not HIV Tests

  2010cites this paper
• Evaluación de la aplicación del ensayo UMELISA HIV 1+2 RECOMBINANT en muestras de sangre seca sobre papel de filtro S & S 903

  2004cites this paper